Maternal and Fetal Problems in Patients with Non-Cystic Fibrosis Bronchiectasis During Pregnancy
- PMID: 35110246
- PMCID: PMC8975312
- DOI: 10.5152/TurkThoracJ.2021.20236
Maternal and Fetal Problems in Patients with Non-Cystic Fibrosis Bronchiectasis During Pregnancy
Abstract
Objective: To detect the maternal and fetal problems experienced by patients with non-cystic fibrosis (non-CF) bronchiectasis during pregnancy.
Material and methods: A total of 185 women aged over 18 years with medical records available, who were diagnosed as having non-CF bronchiectasis and followed in the outpatient clinic for bronchiectasis, were interviewed by phone between November 1, 2019 and December 31, 2019. Forty-seven women who accepted to participate, were able to understand and answer the survey, and had experienced at least 1 pregnancy, were included in the study, The survey questions were read and the answers were recorded. The same survey was administered to a control group of 95 women.
Results: It was found that the number of patients experiencing an increase in at least 1 of the symptoms of cough, sputum production, and dyspnea during pregnancy, and the number of visits to emergency departments for respiratory conditions, were statistically significantly higher (P < .001 and P < .001, respectively), and the rate of live births was significantly lower (P = .009) in the non-CF bronchiectasis group compared with the control group. No significant difference was found between the groups in the number of miscarriages, preterm births, cesarean section, extra visits to the obstetrics department, and the presence of anomalies in the infants.
Conclusion: Among patients with non-CF bronchiectasis, it should be kept in mind that an increase may be seen in respiratory symptoms and the number of emergency department visits during pregnancy, and a decrease may be seen in the ratio of live births. These patients should be followed closely for these issues and measures should be taken accordingly.
Conflict of interest statement
Similar articles
-
Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis.Infect Drug Resist. 2018 Aug 10;11:1137-1143. doi: 10.2147/IDR.S169789. eCollection 2018. Infect Drug Resist. 2018. PMID: 30127630 Free PMC article.
-
Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience.Transplant Proc. 2019 Jul-Aug;51(6):2029-2034. doi: 10.1016/j.transproceed.2019.04.036. Epub 2019 Jul 11. Transplant Proc. 2019. PMID: 31303417
-
[Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].Rev Mal Respir. 2020 Sep;37(7):561-571. doi: 10.1016/j.rmr.2020.06.006. Epub 2020 Jul 16. Rev Mal Respir. 2020. PMID: 32684338 Review. French.
-
Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.JAMA. 2013 Mar 27;309(12):1251-9. doi: 10.1001/jama.2013.1937. JAMA. 2013. PMID: 23532241 Clinical Trial.
-
A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.Respir Med. 2018 Apr;137:35-39. doi: 10.1016/j.rmed.2018.02.013. Epub 2018 Feb 24. Respir Med. 2018. PMID: 29605210 Review.
References
LinkOut - more resources
Full Text Sources